Join a global community of healthcare experts and professionals pursuing clinical effectiveness
If we continue down the path of automation and AI, our workforce is bound to undergo creative transformations
The table below lists our share buyback programs since 2011. In July 2012, Wolters Kluwer introduced a policy to offset the dilution caused by our annual performance share issuance with share repurchases (Anti-dilution Policy). Accordingly, starting in 2012, the share buyback amounts include repurchases to offset the dilution from incentive programs.
| Date Announced | Share Buyback Program | Status |
| February 24, 2021 and subsequently expanded | Up to €410 million, in 2021, including amounts to offset dilution from incentive share issuance. |
In progress For a weekly update, see Share Buyback Transactions |
| February 26, 2020 | Up to €350 million, in 2020, including amounts to offset dilution from incentive share issuance. | Completed December 29, 2020: 5.1 million shares repurchased for €350 million (average price €68.41) |
Etiam eu dolor et ipsum semper cursus accumsan eu eros. Vivamus porttitor hendrerit justo, mattis sagittis sem ultricies nec. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Praesent tempus varius nibh eget rhoncus. Quisque vel metus turpis. Donec iaculis sapien in lorem tristique egestas. Curabitur et scelerisque arcu, pulvinar eleifend dui:
Etiam eu dolor et ipsum semper cursus accumsan eu eros. Vivamus porttitor hendrerit justo, mattis sagittis sem ultricies nec. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Praesent tempus varius nibh eget rhoncus. Quisque vel metus turpis. Donec iaculis sapien in lorem tristique egestas. Curabitur et scelerisque arcu, pulvinar eleifend dui:
Simply send us your contact information and we will gladly reach out.